| Condition or disease | Intervention/treatment |
|---|---|
| Emergencies Triage | Other: Four-level Chinese Emergency triage scale |
| Study Type : | Observational |
| Estimated Enrollment : | 30687 participants |
| Observational Model: | Cohort |
| Time Perspective: | Retrospective |
| Official Title: | The Reliability and Validity of a Four-level Chinese Emergency Triage Scale in Mainland China |
| Actual Study Start Date : | January 1, 2018 |
| Actual Primary Completion Date : | December 31, 2019 |
| Estimated Study Completion Date : | June 30, 2020 |
| Group/Cohort | Intervention/treatment |
|---|---|
|
emergency triage patients
triage Level I triage Level II triage Level III triage Level IV
|
Other: Four-level Chinese Emergency triage scale
a four-level category system, i.e. life-threatening (Level I), emergent (Level II), urgent (Level III) and semi-urgent (Level IV) . This system contains critical indicators (cardiac arrest, shock, and apnea), high risk indicators (ACS and DKA), single objective indicators (SBP, RR, HR, and SpO2) and MEWS (synthesis indicator). According to patients' health care problems, patients are rated by nurses into one of the four mentioned levels.
|
| Ages Eligible for Study: | 14 Years and older (Child, Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Probability Sample |
Inclusion Criteria:
Exclusion Criteria:
| China | |
| SAHZhejiangU | |
| Hangzhou, China, 310009 | |
| Tracking Information | |||||
|---|---|---|---|---|---|
| First Submitted Date | April 22, 2019 | ||||
| First Posted Date | April 24, 2019 | ||||
| Last Update Posted Date | February 12, 2020 | ||||
| Actual Study Start Date | January 1, 2018 | ||||
| Actual Primary Completion Date | December 31, 2019 (Final data collection date for primary outcome measure) | ||||
| Current Primary Outcome Measures |
|
||||
| Original Primary Outcome Measures | Same as current | ||||
| Change History | |||||
| Current Secondary Outcome Measures |
the number of hospitalization [ Time Frame: 2019-12-31 ] | ||||
| Original Secondary Outcome Measures | Same as current | ||||
| Current Other Pre-specified Outcome Measures | Not Provided | ||||
| Original Other Pre-specified Outcome Measures | Not Provided | ||||
| Descriptive Information | |||||
| Brief Title | Effectiveness of a Four-level Chinese Emergency Triage Scale in Mainland China | ||||
| Official Title | The Reliability and Validity of a Four-level Chinese Emergency Triage Scale in Mainland China | ||||
| Brief Summary | Inter-rater reliability between experts and triage nurses was assessed in 484 emergency patients. The criterion-related validity was evaluated in other 30687 emergency patients, based on emergency department (ED) mortality, the length of stay in ED, the number of discharge, and hospitalization (intensive care/general ward). | ||||
| Detailed Description | Not Provided | ||||
| Study Type | Observational | ||||
| Study Design | Observational Model: Cohort Time Perspective: Retrospective |
||||
| Target Follow-Up Duration | Not Provided | ||||
| Biospecimen | Not Provided | ||||
| Sampling Method | Probability Sample | ||||
| Study Population | All eligibility emergency patients | ||||
| Condition |
|
||||
| Intervention | Other: Four-level Chinese Emergency triage scale
a four-level category system, i.e. life-threatening (Level I), emergent (Level II), urgent (Level III) and semi-urgent (Level IV) . This system contains critical indicators (cardiac arrest, shock, and apnea), high risk indicators (ACS and DKA), single objective indicators (SBP, RR, HR, and SpO2) and MEWS (synthesis indicator). According to patients' health care problems, patients are rated by nurses into one of the four mentioned levels.
|
||||
| Study Groups/Cohorts | emergency triage patients
triage Level I triage Level II triage Level III triage Level IV
Intervention: Other: Four-level Chinese Emergency triage scale
|
||||
| Publications * | Not Provided | ||||
|
* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline. |
|||||
| Recruitment Information | |||||
| Recruitment Status | Active, not recruiting | ||||
| Estimated Enrollment |
30687 | ||||
| Original Estimated Enrollment | Same as current | ||||
| Estimated Study Completion Date | June 30, 2020 | ||||
| Actual Primary Completion Date | December 31, 2019 (Final data collection date for primary outcome measure) | ||||
| Eligibility Criteria |
Inclusion Criteria:
Exclusion Criteria:
|
||||
| Sex/Gender |
|
||||
| Ages | 14 Years and older (Child, Adult, Older Adult) | ||||
| Accepts Healthy Volunteers | No | ||||
| Contacts | Contact information is only displayed when the study is recruiting subjects | ||||
| Listed Location Countries | China | ||||
| Removed Location Countries | |||||
| Administrative Information | |||||
| NCT Number | NCT03926234 | ||||
| Other Study ID Numbers | 2018ZH012 | ||||
| Has Data Monitoring Committee | No | ||||
| U.S. FDA-regulated Product |
|
||||
| IPD Sharing Statement |
|
||||
| Responsible Party | Second Affiliated Hospital, School of Medicine, Zhejiang University | ||||
| Study Sponsor | Second Affiliated Hospital, School of Medicine, Zhejiang University | ||||
| Collaborators | Not Provided | ||||
| Investigators | Not Provided | ||||
| PRS Account | Second Affiliated Hospital, School of Medicine, Zhejiang University | ||||
| Verification Date | August 2019 | ||||